All In Biotech

Drug Trial Radar · NCT07601750

Local Anesthetic Clinical Trial

Incidence of Pain During Reanesthetization in Mohs Micrographic Surgery Using Lidocaine, Bupivacaine, Chlorprocaine or Mepivacaine: A Multicenter, Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingRandomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

400

Planned (sponsor's estimate)

Start

Jan 7, 2025

Primary completion

Dec 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Baylor Research InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 22, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 89 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare several local anesthetics when used during dermatological surgery.

Conditions

  • Mohs Micrographic Surgery
  • Anesthesia, Local

Interventions

  • LidocaineDrug

    Standard of Care drug

  • Bupivacaine HydrochlorideDrug

    Study Drug

  • Mepivacaine HydrochlorideDrug

    Study Drug

  • ChlorprocaineDrug

    Study Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determine if pain increases with local injections at each stage of surgery.Time frame: 5 mins, 15 mins, 20 mins, 25 mins, 30 mins, 45 mins (reconstruction)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Baylor University Medical Center

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.